Innoviva (INVA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

INVA Innoviva

Watchlist

17.840
-0.090-0.50%

Close Dec 20 16:00 ET

17.840
0.0000.00%

Post 16:15 ET

1.12BMarket Cap22.30P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Despite Lower Earnings Than Five Years Ago, Innoviva (NASDAQ:INVA) Investors Are up 25% Since Then
Simply Wall StDec 19 05:00 ET
Express News | Innoviva Inc: Innoviva Specialty Therapeutics Anticipates Commercializing Zevtera in Mid-Year 2025
ReutersDec 16 07:01 ET
Express News | Innoviva Inc: Under Terms of Agreement, Innoviva, Inc., Will Be Granted Exclusive Marketing Rights to Zevtera in U.S.
ReutersDec 16 07:00 ET
Express News | Basilea Pharmaceutica AG Allschwil - to Receive $4 Million Upfront Payment, up to $223 Million in Milestones
ReutersDec 16 01:16 ET
Press Release: Basilea Announces Agreement With Innoviva Specialty Therapeutics for the Commercialization of Antibiotic Zevtera(R) (Ceftobiprole) in the United States
Dow JonesDec 16 01:15 ET
Innoviva to Participate in the Citi 2024 Global Healthcare Conference
InnovivaNov 26 00:00 ET

Comments

YawningKitty_x_x

Dec 2 03:09

Columns Santa Rally Incoming? Russell 2000 Steals the Spotlight!

US stock indices are mostly in the green last week, with the Dow Jones leading the way. Asian markets are up too, but Europe? Not so much. On a monthly basis, the US is still crushing it compared to other regions. $Dow Jones Industrial Average (.DJI.US)$ $S&P 500 Index (.SPX.US)$
One standout is the Russell 2000, which jumped 10% in November. That's its best month since July 2024, when it also popped 10%. $iShares Russell 2000 ETF (IWM.US)$
Mak...

Record highs for S&P and Nasdaq: Is the "Santa Rally" on its way?

Moomoo AI

Dec 10, 2023 06:29

Innoviva presents inefficiencies in capital allocation, given its low ROE and stunting earnings growth despite retaining all profits. Comparatively poorer performance to industry's 8.5% growth raises doubts about their reinvestment strategies. Caution advised due to its risk landscape.

Innoviva, Inc. (NASDAQ:INVA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Moomoo AI

Nov 19, 2023 06:37

Recent insider stock sale at Innoviva prompts concern given the timing and scale. The lack of insider ownership paired with their readiness to sell at current prices suggests no urgency to buy shares.

This Insider Has Just Sold Shares In Innoviva

Heat List

Overall

No Data